Stock Events

Stock Events

Japan Tissue Engineering 

¥850
1
-¥26-2.97% 06:30 Today

Statistics

Day High
874
Day Low
840
52W High
898
52W Low
448
Volume
63,000
Avg. Volume
91,490
Mkt Cap
34.52B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-6.19
-3.38
-0.58
2.22
Expected EPS
N/A
Actual EPS
N/A

Financials

-10.4%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
2.46BRevenue
-255.3MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
SanBio Company Limited
4592.TSE
Mkt Cap63.95B
SanBio Co., Ltd. specializes in regenerative medicine for neurological disorders, competing in the broader regenerative medicine space.
CellSeed
7776.TSE
Mkt Cap3.5B
CellSeed Inc. is engaged in the development and commercialization of regenerative medicine products, similar to Japan Tissue Engineering.
Nano
4571.TSE
Mkt Cap14.49B
Nichi-Iko Pharmaceutical Co., Ltd. has a division focused on regenerative medicine, positioning it as a competitor in this niche market.
Medinet
2370.TSE
Mkt Cap20.11B
Medical & Biological Laboratories Co., Ltd. is involved in the research and development of cell therapy products, competing in the same sector.
Recruit.
6098.TSE
Mkt Cap7.38T
MedPeer, Inc. provides a platform for medical data which includes information on regenerative treatments, indirectly competing by influencing treatment choices.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. has investments in regenerative medicine and cell therapy technologies, making it a competitor in the market.
Fujiya.
2211.TSE
Mkt Cap61.35B
Meiji Holdings Co., Ltd., through its pharmaceutical division, explores regenerative medicine, thus competing in the same field.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. invests in the development of new medical solutions including regenerative medicine, aligning as a competitor.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. is heavily involved in innovation in regenerative medicine and therapy, directly competing with Japan Tissue Engineering in the biotechnology and pharmaceutical market.

About

Japan Tissue Engineering Co., Ltd. operates within the regenerative medicine sector in Japan. The company's activities are organized into three core divisions: Regenerative Medicine Product, Regenerative Medicine Outsourcing, and Research and Development Support. It manufactures and delivers autologous cultured tissues, such as epidermis, cartilage, corneal epithelium, and oral mucosal epithelium, to medical institutions for therapeutic applications. The firm also produces other advanced tissue-engineered medical products. Furthermore, Japan Tissue Engineering is involved in the research and development of three-dimensional human cultured tissue models, which are utilized in the development of external-use cosmetics and drugs, as well as for scientific investigations concerning skin and corneal tissues. Additionally, the company provides comprehensive contract development and manufacturing services for regenerative medicine. Established in 1999, Japan Tissue Engineering Co., Ltd. is based in Gamagori, Japan, and functions as a subsidiary of Teijin Limited.
Show more...
CEO
Kazuto Yamada
Employees
200
Country
Japan
ISIN
JP3389610001

Listings

TSE
JP
7774.TSE

0 Comments

Share your thoughts

FAQ

What is Japan Tissue Engineering stock price today?▼
The current price of 7774.TSE is ¥850 JPY — it has decreased by -2.97% in the past 24 hours. Watch Japan Tissue Engineering stock price performance more closely on the chart.
What is Japan Tissue Engineering stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Japan Tissue Engineering stocks are traded under the ticker 7774.TSE.
Is Japan Tissue Engineering stock price growing?▼
7774.TSE stock has fallen by -2.75% compared to the previous week, the month change is a +12.73% rise, over the last year Japan Tissue Engineering has showed a +70.68% increase.
What is Japan Tissue Engineering market cap?▼
Today Japan Tissue Engineering has the market capitalization of 34.52B
When is the next Japan Tissue Engineering earnings date?▼
Japan Tissue Engineering is going to release the next earnings report on November 04, 2026.
What were Japan Tissue Engineering earnings last quarter?▼
7774.TSE earnings for the last quarter are 1.27 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Japan Tissue Engineering revenue for the last year?▼
Japan Tissue Engineering revenue for the last year amounts to 2.46B JPY.
What is Japan Tissue Engineering net income for the last year?▼
7774.TSE net income for the last year is -255.3M JPY.
How many employees does Japan Tissue Engineering have?▼
As of September 04, 2026, the company has 200 employees.
In which sector is Japan Tissue Engineering located?▼
Japan Tissue Engineering operates in the Health & Wellness sector.
When did Japan Tissue Engineering complete a stock split?▼
The last stock split for Japan Tissue Engineering was on March 27, 2014 with a ratio of 200:1.
Where is Japan Tissue Engineering headquartered?▼
Japan Tissue Engineering is headquartered in Gamagori, Japan.